DarioHealth Corp

For the period ended Dec 31, 2023. Filed Mar 28, 2024.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Mar 28, 2024

DRIO$2.06-13.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Comprehensive Loss


· · Year ended
· · December 31,
	2023	2022

Revenues:
Services	$13,084		$17,859
Consumer hardware	7,268		9,797
Total revenues	20,352		27,656

Cost of revenues:
Services	4,679		5,324
Consumer hardware	5,303		8,320
Amortization of acquired intangible assets	4,386		4,357
Total cost of revenues	14,368		18,001

Gross profit	5,984		9,655

Operating expenses:
Research and development	$20,248		$19,649
Sales and marketing	23,785		30,323
General and administrative	18,140		16,493

Total operating expenses	62,173		66,465

Operating loss	56,189		56,810

Total financial expenses, net	3,174		5,379

Loss before taxes	59,363		62,189

Income Tax	64		4

Net loss	$59,427		$62,193


Deemed dividend	$4,084		$1,643

Net loss attributable to shareholders	$63,511		$63,836

Net loss per share:

Basic and diluted loss per share of common stock	$1.93		$2.54
Weighted average number of common stock used in computing basic and diluted net loss per share	28,371,979		23,635,038

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.